Waters Corp (FRA:WAZ)
€ 330.4 +20 (+6.44%) Market Cap: 31.86 Bil Enterprise Value: 36.34 Bil PE Ratio: 46.91 PB Ratio: 2.37 GF Score: 92/100

Waters Corp at JPMorgan Healthcare Conference Transcript

Jan 12, 2026 / 10:15PM GMT
Release Date Price: €334 (-0.68%)
Casey Woodring
JPMorgan Chase & Co - Analyst

All right. Great. Welcome to JPMorgan Healthcare Conference.

I'm Casey Woodring from the Life Science Tools & Diagnostics team. Pleased to be joined by Waters' CEO, Udit Batra.

Udit is going to go through the corporate presentation. And then, we'll leave some time at the end for Q&A. Udit, all you.

Udit Batra
Waters Corp - President, Chief Executive Officer, Director

Thank you, Casey. Good afternoon, everyone.

Roughly five years ago, we started a transformation process that has led to an increase in our commercial strength, revitalization of innovation, and entry into fast-growing adjacencies for Waters. That has then allowed us to make the acquisition of BD's Biosciences and Diagnostics business.

Today, I'll talk to you a bit about how we're executing from a position of strength; with the acquisition of BD's Biosciences and Diagnostics business, how we see the next few years for value creation for our corporation; and, finally, I'll give you a bit of a hint on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot